Galangin inhibits tumor growth and metastasis of B16F10 melanoma

Journal of Cellular Biochemistry

Volumn 114, Issue 1, 2013, Pages 152-161

  Zhang, Wenjing ^a   Tang, Bo ^b   Huang, Qilai ^a,b   Hua, Zichun ^a,b  

^a MACAU UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Macao)

^b NANJING UNIVERSITY   (China)

Author keywords

FAK; GALANGIN; MALIGNANT MELANOMA; METASTASIS

Indexed keywords

F ACTIN; FOCAL ADHESION KINASE; GALANGIN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TYROSINE;

ALPINIA OFFICINARUM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL ADHESION; CELL INVASION; CELL MOTILITY; CELL PROLIFERATION; CELL SPREADING; CELL SURVIVAL; CLONOGENESIS; CONTROLLED STUDY; DRUG CYTOTOXICITY; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; LUNG PARENCHYMA; MELANOMA; METASTASIS INHIBITION; MOUSE; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ACTINS; ALPINIA; ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLAVONOIDS; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; NEOPLASM INVASIVENESS; PHOSPHORYLATION; RNA, MESSENGER; SIGNAL TRANSDUCTION; SKIN NEOPLASMS; TUMOR CELLS, CULTURED;

ALPINIA OFFICINARUM;

EID: 84869438296     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24312     Document Type: Article

References (52)

1. Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE, Price JE,. 2005. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res 11: 7490-7498.
2. Amaria RN, Lewis KD, Jimeno A,. 2012. Vemurafenib: The road to personalized medicine in melanoma. Drugs Today (Barc) 48: 109-118.
3. Bacac M, Stamenkovic I,. 2008. Metastatic cancer cell. Annu Rev Pathol 3: 221-247.
4. Boyle GM,. 2011. Therapy for metastatic melanoma: An overview and update. Expert Rev Anticancer Ther 11: 725-737.
5. Chambers AF, Groom AC, MacDonald IC,. 2002. Dissemination and growth of cancer cells in metastatic sites. Nat Rev Cancer 2: 563-572.
6. Chaturvedi MM, Sung B, Yadav VR, Kannappan R, Aggarwal BB,. 2011. NF-kappaB addiction and its role in cancer: 'One size does not fit all'. Oncogene 30: 1615-1630.
7. Chatzizacharias NA, Kouraklis GP, Theocharis SE,. 2007. Focal adhesion kinase: A promising target for anticancer therapy. Expert Opin Ther Targets 11: 1315-1328.
8. Chen Y, Bathula SR, Yang Q, Huang L,. 2010. Targeted nanoparticles deliver siRNA to melanoma. J Invest Dermatol 130: 2790-2798.
9. Cummins DL, Cummins JM, Pantle H, Silverman MA, Leonard AL, Chanmugam A,. 2006. Cutaneous malignant melanoma. Mayo Clin Proc 81: 500-507.
10. Defilippi P, Olivo C, Venturino M, Dolce L, Silengo L, Tarone G,. 1999. Actin cytoskeleton organization in response to integrin-mediated adhesion. Microsc Res Tech 47: 67-78.
11. Finn L, Markovic SN, Joseph RW,. 2012. Therapy for metastatic melanoma: The past, present, and future. BMC Med 10: 23.
12. Franken NA, Rodermond HM, Stap J, Haveman J, van Bree C,. 2006. Clonogenic assay of cells in vitro. Nat Protoc 1: 2315-2319.
13. Frisch SM, Vuori K, Ruoslahti E, Chan-Hui PY,. 1996. Control of adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134: 793-799.
14. Gogas HJ, Kirkwood JM, Sondak VK,. 2007. Chemotherapy for metastatic melanoma: Time for a change ? Cancer 109: 455-464.
15. Golubovskaya VM,. 2010. Focal adhesion kinase as a cancer therapy target. Anticancer Agents Med Chem 10: 735-741.
16. Golubovskaya V, Kaur A, Cance W,. 2004. Cloning and characterization of the promoter region of human focal adhesion kinase gene: Nuclear factor kappa B and p53 binding sites. Biochim Biophys Acta 1678: 111-125.
17. Gupta GP, Massague J,. 2006. Cancer metastasis: Building a framework. Cell 127: 679-695.
18. Gupta SC, Kim JH, Prasad S, Aggarwal BB,. 2010. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 29: 405-434.
19. Gwak J, Oh J, Cho M, Bae SK, Song IS, Liu KH, Jeong Y, Kim DE, Chung YH, Oh S,. 2011. Galangin suppresses the proliferation of beta-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3beta-independent beta-catenin degradation. Mol Pharmacol 79: 1014-1022.
20. Hall JE, Fu W, Schaller MD,. 2011. Focal adhesion kinase: Exploring Fak structure to gain insight into function. Int Rev Cell Mol Biol 288: 185-225.
21. Heng MC,. 2010. Curcumin targeted signaling pathways: Basis for anti-photoaging and anti-carcinogenic therapy. Int J Dermatol 49: 608-622.
22. Heo MY, Sohn SJ, Au WW,. 2001. Anti-genotoxicity of galangin as a cancer chemopreventive agent candidate. Mutat Res 488: 135-150.
23. Hess AR, Hendrix MJ,. 2006. Focal adhesion kinase signaling and the aggressive melanoma phenotype. Cell Cycle 5: 478-480.
24. Hocker TL, Singh MK, Tsao H,. 2008. Melanoma genetics and therapeutic approaches in the 21st century: Moving from the benchside to the bedside. J Invest Dermatol 128: 2575-2595.
25. Huang YT, Lee LT, Lee PP, Lin YS, Lee MT,. 2005. Targeting of focal adhesion kinase by flavonoids and small-interfering RNAs reduces tumor cell migration ability. Anticancer Res 25 (3B): 2017-2025.
26. Kucik DF, Wu C,. 2005. Cell-adhesion assays. Methods Mol Biol 294: 43-54.
27. Lee YH, Kumar NC, Glickman RD,. 2012. Modulation of photochemical damage in normal and malignant cells by naturally-occurring compounds(+). Photochem Photobiol. DOI: 10.1111/j.1751-1097.2012.01156.x.
28. Li S, Hua ZC,. 2008. FAK expression regulation and therapeutic potential. Adv Cancer Res 101: 45-61.
29. Li Y, Sarkar FH,. 2002. Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin Cancer Res 8: 2369-2377.
30. Li X, Regezi J, Ross FP, Blystone S, Ilić D, Leong SP, Ramos DM,. 2001. Integrin alphavbeta3 mediates K1735 murine melanoma cell motility in vivo and in vitro. J Cell Sci 114: 2665-2672.
31. Li S, Dong W, Zong Y, Yin W, Jin G, Hu Q, Huang X, Jiang W, Hua ZC,. 2007. Polyethylenimine-complexed plasmid particles targeting focal adhesion kinase function as melanoma tumor therapeutics. Mol Ther 15: 515-523.
32. Liang CC, Park AY, Guan JL,. 2007. In vitro scratch assay: A convenient and inexpensive method for analysis of cell migration in vitro. Nat Protoc 2: 329-333.
33. Liao YF, Rao YK, Tzeng YM,. 2012. Aqueous extract of Anisomeles indica and its purified compound exerts anti-metastatic activity through inhibition of NF-kappaB/AP-1-dependent MMP-9 activation in human breast cancer MCF-7 cells. Food Chem Toxicol 50: 2930-2936.
34. Lin Y, Shi R, Wang X, Shen HM,. 2008. Luteolin, a flavonoid with potential for cancer prevention and therapy. Curr Cancer Drug Targets 8: 634-646.
35. Lin CW, Shen SC, Chien CC, Yang LY, Shia LT, Chen YC,. 2010. 12-O-tetradecanoylphorbol-13-acetate-induced invasion/migration of glioblastoma cells through activating PKCalpha/ERK/NF-kappaB-dependent MMP-9 expression. J Cell Physiol 225: 472-481.
36. Liu PL, Tsai JR, Charles AL, Hwang JJ, Chou SH, Ping YH, Lin FY, Chen YL, Hung CY, Chen WC, Chen YH, Chong IW,. 2010. Resveratrol inhibits human lung adenocarcinoma cell metastasis by suppressing heme oxygenase 1-mediated nuclear factor-kappaB pathway and subsequently downregulating expression of matrix metalloproteinases. Mol Nutr Food Res 54 (Suppl. 2): S196-S204.
37. Luo M, Guan JL,. 2010. Focal adhesion kinase: A prominent determinant in breast cancer initiation, progression and metastasis. Cancer Lett 289: 127-139.
38. Manna SK, Mukhopadhyay A, Aggarwal BB,. 2000. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid peroxidation. J Immunol 164: 6509-6519.
39. Murray TJ, Yang X, Sherr DH,. 2006. Growth of a human mammary tumor cell line is blocked by galangin, a naturally occurring bioflavonoid, and is accompanied by down-regulation of cyclins D3, E, and A. Breast Cancer Res 8: R17.
40. Naugler WE, Karin M,. 2008. NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18: 19-26.
41. Parekh HS, Liu G, Wei MQ,. 2009. A new dawn for the use of traditional Chinese medicine in cancer therapy. Mol Cancer 8: 21.
42. Pisano M, Pagnan G, Loi M, Mura ME, Tilocca MG, Palmieri G, Fabbri D, Dettori MA, Delogu G, Ponzoni M, Rozzo C,. 2007. Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells. Mol Cancer 6: 8.
43. Qi F, Li A, Inagaki Y, Gao J, Li J, Kokudo N, Li XK, Tang W,. 2010. Chinese herbal medicines as adjuvant treatment during chemo- or radio-therapy for cancer. Biosci Trends 4: 297-307.
44. Russo A, Longo R, Vanella A,. 2002. Antioxidant activity of propolis: Role of caffeic acid phenethyl ester and galangin. Fitoterapia 73 (Suppl 1): S21-S29.
45. Schultze A, Fiedler W,. 2010. Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer. Expert Opin Investig Drugs 19: 777-788.
46. Shore RN, Shore P, Monahan NM, Sundeen J,. 2011. Serial screening for melanoma: Measures and strategies that have consistently achieved early detection and cure. J Drugs Dermatol 10: 244-252.
47. Smith CS, Golubovskaya VM, Peck E, Xu LH, Monia BP, Yang X, Cance WG,. 2005. Effect of focal adhesion kinase (FAK) downregulation with FAK antisense oligonucleotides and 5-fluorouracil on the viability of melanoma cell lines. Melanoma Res 15: 357-362.
48. Sohn SJ, Huh IH, Au WW, Heo MY,. 1998. Antigenotoxicity of galangin against N-methyl-N-nitrosourea. Mutat Res 402: 231-236.
49. Tiong KH, Yiap BC, Tan EL, Ismail R, Ong CE,. 2010. In vitro modulation of naturally occurring flavonoids on cytochrome P450 2A6 (CYP2A6) activity. Xenobiotica 40: 458-466.
50. Ulbricht CE, Chao W,. 2010. Phytochemicals in the oncology setting. Curr Treat Options Oncol 11: 95-106.
51. Whitney GS, Chan PY, Blake J, Cosand WL, Neubauer MG, Aruffo A, Kanner SB,. 1993. Human T and B lymphocytes express a structurally conserved focal adhesion kinase, pp125FAK. DNA Cell Biol 12: 823-830.
52. Zhang HT, Luo H, Wu J, Lan LB, Fan DH, Zhu KD, Chen XY, Wen M, Liu HM,. 2010. Galangin induces apoptosis of hepatocellular carcinoma cells via the mitochondrial pathway. World J Gastroenterol 16: 3377-3384.